Cargando…
Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma
Purpose: The incidence of esophageal adenocarcinoma (EAC) has increased by 700% in Western countries over the last 30 years. Although clinical guidelines call for endoscopic surveillance for EAC among high-risk populations, fewer than 5% of new EAC patients are under surveillance at the time of diag...
Autores principales: | Zhou, Zhongren, Kalatskaya, Irina, Russell, Donna, Marcon, Norman, Cirocco, Maria, Krzyzanowski, Paul M, Streutker, Cathy, Liang, Hua, Litle, Virginia R, Godfrey, Tony E, Stein, Lincoln |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527096/ https://www.ncbi.nlm.nih.gov/pubmed/31190949 http://dx.doi.org/10.2147/CEG.S186958 |
Ejemplares similares
-
Predictors of Malignancy in Patients With Indeterminate Biliary Strictures and Atypical Biliary Cytology: Results From Retrospective Cohort Study
por: Alali, Ali, et al.
Publicado: (2021) -
The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry
por: Lee, Byoung Hwan, et al.
Publicado: (2012) -
Treatment of Dysplasia in Barrett Esophagus
por: Aranda-Hernandez, Javier, et al.
Publicado: (2014) -
Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population
por: Abadir, Amir, et al.
Publicado: (2012) -
Advanced Imaging Technologies for the Detection of Dysplasia and Early Cancer in Barrett Esophagus
por: Espino, Alberto, et al.
Publicado: (2014)